As Gilead Sciences (GILD) Stock Value Rose, Holder Needham Investment Management Has Cut Position by $674,500; As Marathon Pete (MPC) Share Value Rose, Shareholder Arosa Capital Management LP Has Trimmed by $10.00 Million Its Position

April 24, 2018 - By David Stenberg

Marathon Petroleum Corporation (NYSE:MPC) Logo

Needham Investment Management Llc decreased its stake in Gilead Sciences Inc (GILD) by 5.57% based on its latest 2017Q4 regulatory filing with the SEC. Needham Investment Management Llc sold 9,500 shares as the company’s stock rose 1.93% while stock markets declined. The institutional investor held 161,000 shares of the health care company at the end of 2017Q4, valued at $11.53M, down from 170,500 at the end of the previous reported quarter. Needham Investment Management Llc who had been investing in Gilead Sciences Inc for a number of months, seems to be less bullish one the $94.73 billion market cap company. The stock decreased 1.83% or $1.3556 during the last trading session, reaching $72.6544. About 3.32 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since April 24, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

Arosa Capital Management Lp decreased its stake in Marathon Pete Corp (MPC) by 63.24% based on its latest 2017Q4 regulatory filing with the SEC. Arosa Capital Management Lp sold 153,790 shares as the company’s stock rose 9.83% while stock markets declined. The institutional investor held 89,376 shares of the integrated oil company at the end of 2017Q4, valued at $5.90M, down from 243,166 at the end of the previous reported quarter. Arosa Capital Management Lp who had been investing in Marathon Pete Corp for a number of months, seems to be less bullish one the $37.78 billion market cap company. The stock decreased 0.26% or $0.21 during the last trading session, reaching $79.64. About 2.97 million shares traded. Marathon Petroleum Corporation (NYSE:MPC) has risen 49.25% since April 24, 2017 and is uptrending. It has outperformed by 37.70% the S&P500.

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on May, 1 after the close. They expect $1.59 EPS, down 27.73% or $0.61 from last year’s $2.2 per share. GILD’s profit will be $2.07 billion for 11.42 P/E if the $1.59 EPS becomes a reality. After $1.60 actual EPS reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -0.63% negative EPS growth.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 126 analyst reports since July 29, 2015 according to SRatingsIntel. Gabelli initiated the shares of GILD in report on Wednesday, June 1 with “Buy” rating. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Hold” rating by Credit Suisse on Wednesday, January 3. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Neutral” rating given on Monday, January 18 by Bank of America. The rating was maintained by Jefferies with “Hold” on Wednesday, August 31. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Buy” rating by Maxim Group on Wednesday, October 28. The company was maintained on Wednesday, June 14 by William Blair. The firm has “Hold” rating by Oppenheimer given on Thursday, December 21. On Friday, September 15 the stock rating was maintained by Robert W. Baird with “Buy”. Jefferies reinitiated the stock with “Hold” rating in Tuesday, July 11 report. Maxim Group downgraded the shares of GILD in report on Friday, April 29 to “Hold” rating.

Since January 2, 2018, it had 0 insider purchases, and 18 insider sales for $39.95 million activity. 50,000 shares were sold by MARTIN JOHN C, worth $3.93 million on Thursday, March 1. Another trade for 100,000 shares valued at $8.02 million was sold by Meyers James R. 30,000 shares were sold by Alton Gregg H, worth $2.37 million on Thursday, January 11. $401,566 worth of stock was sold by Washington Robin L on Wednesday, February 21. Cogan John Francis sold 5,833 shares worth $467,138.

Investors sentiment decreased to 0.8 in 2017 Q4. Its down 0.23, from 1.03 in 2017Q3. It is negative, as 95 investors sold GILD shares while 545 reduced holdings. 104 funds opened positions while 411 raised stakes. 972.68 million shares or 1.57% more from 957.62 million shares in 2017Q3 were reported. Utah Retirement System reported 242,086 shares stake. Strategic Ltd Liability Corp accumulated 11,654 shares or 0.34% of the stock. Bahl & Gaynor owns 27,716 shares. Great Lakes Advsrs Ltd Liability Company reported 0.12% stake. Lipe & Dalton reported 2.45% in Gilead Sciences, Inc. (NASDAQ:GILD). 362,788 are owned by Beck Mack Oliver Llc. Sigma Planning holds 0.17% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 30,641 shares. Patten Gp Inc has invested 0.01% in Gilead Sciences, Inc. (NASDAQ:GILD). Capital Counsel Lc Ny holds 0.41% or 69,880 shares. National Mutual Federation Of Agricultural Cooperatives owns 24,500 shares for 0.03% of their portfolio. Dubuque National Bank & Trust And Tru reported 1,469 shares stake. Arrow Fincl reported 9,726 shares. Carnegie Capital Asset Mngmt Limited Liability Corp owns 10,765 shares for 0.08% of their portfolio. Moreover, Quinn Opportunity Prtn Limited Company has 0.74% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Cullinan Assoc has invested 0.06% in Gilead Sciences, Inc. (NASDAQ:GILD).

Since December 12, 2017, it had 1 insider buy, and 5 selling transactions for $8.42 million activity. On Tuesday, December 12 Palmer C. Michael sold $1.12 million worth of Marathon Petroleum Corporation (NYSE:MPC) or 17,298 shares. BUNCH CHARLES E bought 1,500 shares worth $101,070. 20,000 shares valued at $1.40M were sold by Kelley Thomas M. on Tuesday, March 13.

Arosa Capital Management Lp, which manages about $456.37 million and $651.63 million US Long portfolio, upped its stake in Westlake Chem Corp (NYSE:WLK) by 36,810 shares to 74,910 shares, valued at $7.98 million in 2017Q4, according to the filing. It also increased its holding in Noble Energy Inc (NYSE:NBL) by 406,249 shares in the quarter, for a total of 706,249 shares, and has risen its stake in Sunrun Inc.

Investors sentiment increased to 0.96 in 2017 Q4. Its up 0.05, from 0.91 in 2017Q3. It improved, as 37 investors sold MPC shares while 316 reduced holdings. 118 funds opened positions while 222 raised stakes. 367.91 million shares or 3.23% less from 380.18 million shares in 2017Q3 were reported. Ancora Advsr Limited Liability Co invested 0.41% in Marathon Petroleum Corporation (NYSE:MPC). Old Point Tru Fin Ser N A holds 6,607 shares. Mai Capital Management holds 0.4% of its portfolio in Marathon Petroleum Corporation (NYSE:MPC) for 107,931 shares. 878,585 were accumulated by Strs Ohio. Moreover, Commercial Bank Of Nova Scotia has 0.03% invested in Marathon Petroleum Corporation (NYSE:MPC). First Personal Fin Ser owns 1,485 shares for 0.02% of their portfolio. Sumitomo Life Insurance has invested 0.45% in Marathon Petroleum Corporation (NYSE:MPC). Boston Advisors Ltd Liability Corp holds 0.16% or 110,582 shares. Lsv Asset Management stated it has 3.49 million shares. Nippon Life Global Investors Americas reported 0.21% stake. Chevy Chase Tru Holding Inc holds 0.12% of its portfolio in Marathon Petroleum Corporation (NYSE:MPC) for 430,530 shares. Sumitomo Mitsui Asset Mgmt Co holds 0.05% of its portfolio in Marathon Petroleum Corporation (NYSE:MPC) for 54,012 shares. Fincl Architects holds 460 shares or 0.01% of its portfolio. Rampart Mgmt Limited Liability Corp accumulated 0.16% or 6,209 shares. Chemical Fincl Bank has 21,203 shares for 0.15% of their portfolio.

Analysts await Marathon Petroleum Corporation (NYSE:MPC) to report earnings on May, 1 before the open. They expect $0.24 earnings per share, up 300.00% or $0.18 from last year’s $0.06 per share. MPC’s profit will be $113.86 million for 82.96 P/E if the $0.24 EPS becomes a reality. After $1.05 actual earnings per share reported by Marathon Petroleum Corporation for the previous quarter, Wall Street now forecasts -77.14% negative EPS growth.

Among 20 analysts covering Marathon Petroleum Corp (NYSE:MPC), 14 have Buy rating, 0 Sell and 6 Hold. Therefore 70% are positive. Marathon Petroleum Corp had 85 analyst reports since August 10, 2015 according to SRatingsIntel. On Tuesday, February 13 the stock rating was upgraded by Goldman Sachs to “Buy”. As per Friday, October 28, the company rating was maintained by Howard Weil. The stock of Marathon Petroleum Corporation (NYSE:MPC) earned “Strong-Buy” rating by Vetr on Tuesday, August 11. The stock of Marathon Petroleum Corporation (NYSE:MPC) earned “Buy” rating by Piper Jaffray on Thursday, July 13. The rating was maintained by Cowen & Co with “Buy” on Tuesday, October 17. The rating was downgraded by Wells Fargo on Monday, February 5 to “Sell”. RBC Capital Markets maintained the shares of MPC in report on Friday, April 20 with “Buy” rating. The stock of Marathon Petroleum Corporation (NYSE:MPC) earned “Buy” rating by Vetr on Monday, August 24. Deutsche Bank maintained the shares of MPC in report on Monday, March 19 with “Buy” rating. Morgan Stanley maintained it with “Overweight” rating and $95 target in Monday, April 16 report.

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 David Stenberg

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts